Azza A A Galal
Overview
Explore the profile of Azza A A Galal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ibrahim H, Abd El-Alim A, El-Hafeez M, Metwally M, Khamis T, Galal A
Life Sci
. 2023 Feb;
319:121523.
PMID: 36842762
Aim: We investigated the ability of baicalein (BAI) to enhance the anticancer potential of capecitabine (CAP) in the MCF-7 cell line and its protective effect on CAP-induced cardiotoxicity in female...
2.
El-Sheikh S, Metwally A, Galal A
Therapie
. 2022 Jun;
78(3):313-324.
PMID: 35717337
Aim Of Study: To assess the impact of diabetes mellitus on plasma concentration and bioavailability of rifampicin. Methods: Web of Science, Cochrane Library, PubMed and Scopus databases were screened until...
3.
Said A, Nasr Y, Galal A, Abdelhamid A, Mohamed H, Metwally M, et al.
Life (Basel)
. 2022 May;
12(5).
PMID: 35629307
: Due to the increased use of titanium dioxide nanoparticles (TiO NPs), the risks of their reprotoxic effect arise. This study anticipated examining the potential protective effects of GEO (geranium...
4.
El-Sheikh S, Bahaa H, Galal A, Metwally M, Said M, Alattar R, et al.
Saudi J Biol Sci
. 2022 May;
29(6):103289.
PMID: 35521358
Acetylsalicylic acid (Aspirin) has been used for a long time as an antipyretic and analgesic. Nevertheless, aspirin use is associated with severe morbidity and death because of its detrimental impacts...
5.
Metwally A, El-Sheikh S, Galal A
Diabetes Metab Syndr
. 2022 Feb;
16(2):102410.
PMID: 35144181
Background And Aims: Diabetes mellitus has a negative impact on the treatment outcome of tuberculosis, increasing the incidence of treatment failure and relapse. There is a scarcity of knowledge concerning...
6.
El-Sheikh S, Abd El-Alim A, Ibrahim H, Mobarez E, El-Sayed W, Galal A, et al.
J Med Microbiol
. 2021 Oct;
70(10).
PMID: 34612810
The emergence of multidrug-resistant strains has increased the need for safe, alternative therapies from natural sources with antibacterial properties. There are no published data regarding the use of chitosan propolis...
7.
El-Sheikh S, Edrees N, El-Sayed H, Khamis T, Arisha A, Metwally M, et al.
Biol Trace Elem Res
. 2021 Mar;
200(2):582-590.
PMID: 33759109
Nanotechnology is a possible solution to the drawbacks of cancer therapy because it decreases the clinical side effects of chemotherapeutic drugs and increases their clinical activity. Thus, this work compared...
8.
El-Sheikh S, Youssef F, Mohamed H, El-Saber Batiha G, Albrakati A, Galal A
Vet Med Sci
. 2021 Feb;
7(3):923-934.
PMID: 33590677
Pasteurellosis is one of the rabbit's most bacterial severe diseases and leads to considerable financial damages in large production systems worldwide. Antibiotic use in animals may lead to antibiotic residues...
9.
El-Sheikh S, Eleiwa N, Khairy G, El-Aziz R, Metwally M, Galal A
Andrologia
. 2021 Jan;
53(4):e13983.
PMID: 33474736
In this study, we examined the adverse consequences of prolonged treatment with sildenafil and/or clomipramine (CLO) on the hepatic, cardiac and testicular tissues of rats. Additionally, we investigated the potential...
10.
El-Sheikh S, Khairy M, Osama E, Metwally M, Galal A
Naunyn Schmiedebergs Arch Pharmacol
. 2020 Oct;
394(4):631-643.
PMID: 33104848
Nanotechnology has become a promising approach for addressing cancer therapy limitations because it reduces side effects and increases the efficacy of antineoplastic agents. Therefore, this research was designed to compare...